BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 11518071)

  • 21. Characterization of pregnancies exposed to St. John's wort and their outcomes: A claims data analysis.
    Schäfer W; Wentzell N; Schink T; Haug U
    Reprod Toxicol; 2021 Jun; 102():90-97. PubMed ID: 33961968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [St. John's wort (Hypericum perforatum L.). A plant with relevance for dermatology].
    Schempp CM; Müller KA; Winghofer B; Schöpf E; Simon JC
    Hautarzt; 2002 May; 53(5):316-21. PubMed ID: 12063742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole.
    Wang LS; Zhou G; Zhu B; Wu J; Wang JG; Abd El-Aty AM; Li T; Liu J; Yang TL; Wang D; Zhong XY; Zhou HH
    Clin Pharmacol Ther; 2004 Mar; 75(3):191-7. PubMed ID: 15001970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Meta-analysis of effectiveness and tolerability of treatment of mild to moderate depression with St. John's Wort].
    Röder C; Schaefer M; Leucht S
    Fortschr Neurol Psychiatr; 2004 Jun; 72(6):330-43. PubMed ID: 15211398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of St John's wort in major depression: a randomized controlled trial.
    Shelton RC; Keller MB; Gelenberg A; Dunner DL; Hirschfeld R; Thase ME; Russell J; Lydiard RB; Crits-Cristoph P; Gallop R; Todd L; Hellerstein D; Goodnick P; Keitner G; Stahl SM; Halbreich U
    JAMA; 2001 Apr; 285(15):1978-86. PubMed ID: 11308434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intake of St John's wort improves the glucose tolerance in healthy subjects who ingest metformin compared with metformin alone.
    Stage TB; Pedersen RS; Damkier P; Christensen MM; Feddersen S; Larsen JT; Højlund K; Brøsen K
    Br J Clin Pharmacol; 2015 Feb; 79(2):298-306. PubMed ID: 25223504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mania during the use of a combination preparation with St. John's wort (Hypericum perforatum)].
    Güzelcan Y; Scholte WF; Assies J; Becker HE
    Ned Tijdschr Geneeskd; 2001 Oct; 145(40):1943-5. PubMed ID: 11675976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4.
    Dürr D; Stieger B; Kullak-Ublick GA; Rentsch KM; Steinert HC; Meier PJ; Fattinger K
    Clin Pharmacol Ther; 2000 Dec; 68(6):598-604. PubMed ID: 11180019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. St John's wort greatly decreases the plasma concentrations of oral S-ketamine.
    Peltoniemi MA; Saari TI; Hagelberg NM; Laine K; Neuvonen PJ; Olkkola KT
    Fundam Clin Pharmacol; 2012 Dec; 26(6):743-50. PubMed ID: 21635359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
    Jiang X; Williams KM; Liauw WS; Ammit AJ; Roufogalis BD; Duke CC; Day RO; McLachlan AJ
    Br J Clin Pharmacol; 2004 May; 57(5):592-9. PubMed ID: 15089812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.
    Barnes J; Anderson LA; Phillipson JD
    J Pharm Pharmacol; 2001 May; 53(5):583-600. PubMed ID: 11370698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. St John's wort and depression: slight efficacy at best, many drug interactions.
    Prescrire Int; 2004 Oct; 13(73):187-92. PubMed ID: 15499702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.
    Fava M; Alpert J; Nierenberg AA; Mischoulon D; Otto MW; Zajecka J; Murck H; Rosenbaum JF
    J Clin Psychopharmacol; 2005 Oct; 25(5):441-7. PubMed ID: 16160619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. St John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind study.
    Kobak KA; Taylor LV; Bystritsky A; Kohlenberg CJ; Greist JH; Tucker P; Warner G; Futterer R; Vapnik T
    Int Clin Psychopharmacol; 2005 Nov; 20(6):299-304. PubMed ID: 16192837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The recovery time-course of CYP3A after induction by St John's wort administration.
    Imai H; Kotegawa T; Tsutsumi K; Morimoto T; Eshima N; Nakano S; Ohashi K
    Br J Clin Pharmacol; 2008 May; 65(5):701-7. PubMed ID: 18294328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. St John's Wort supplements endanger the success of organ transplantation.
    Ernst E
    Arch Surg; 2002 Mar; 137(3):316-9. PubMed ID: 11888457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential therapy of mild to moderate depressive episodes (ICD-10 F 32.0; F 32.1) with St. John's wort.
    Friede M; Henneicke von Zepelin HH; Freudenstein J
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S38-41. PubMed ID: 11518073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. About the cover: St. John's wort.
    J Soc Integr Oncol; 2006; 4(1):52-5. PubMed ID: 16737673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of St. John's wort for the treatment of major depression.
    Nangia M; Syed W; Doraiswamy PM
    Public Health Nutr; 2000 Dec; 3(4A):487-94. PubMed ID: 11276296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preserved pharmacological activity of hepatocytes-treated extracts of valerian and St. John's wort.
    Simmen U; Saladin C; Kaufmann P; Poddar M; Wallimann C; Schaffner W
    Planta Med; 2005 Jul; 71(7):592-8. PubMed ID: 16041642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.